Not available
Quote | Catalent Inc. (NYSE:CTLT)
Last: | $56.675 |
---|---|
Change Percent: | 0.29% |
Open: | $56.59 |
Close: | $56.51 |
High: | $56.75 |
Low: | $56.435 |
Volume: | 404,844 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Catalent Inc. (NYSE:CTLT)
2024-06-30 17:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 07:15:04 ET Barclays analyst issues EQUAL-WEIGHT recommendation for CTLT on June 28, 2024 05:28AM ET. The previous analyst recommendation was Equal-Weight. CTLT was trading at $56.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Message Board Posts | Catalent Inc. (NYSE:CTLT)
Subject | By | Source | When |
---|---|---|---|
$CTLT Price gaining | Trend-Setter | investorshub | 05/15/2023 1:27:46 PM |
$CTLT just the news we needed | Trend-Setter | investorshub | 05/13/2023 12:30:00 PM |
MomentumIts trading last trade up | Phosphene | investorshub | 05/09/2023 5:32:12 PM |
short squeeze article | Trend-Setter | investorshub | 05/08/2023 1:36:32 PM |
32-36 https://ih.advfn.com/stock-market/NYSE/catalent-CTLT/stock-news/90985540/c | TheFinalCD | investorshub | 05/08/2023 1:25:41 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-06-30 17:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 07:15:04 ET Barclays analyst issues EQUAL-WEIGHT recommendation for CTLT on June 28, 2024 05:28AM ET. The previous analyst recommendation was Equal-Weight. CTLT was trading at $56.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Catalent, Inc. (NYSE: CTLT) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 3.37% on the day to $56.66. Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologi...